The Arthritis Monoclonal Antibodies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Arthritis Monoclonal Antibodies Market:
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report
According to The Business Research Company’s Arthritis Monoclonal Antibodies Global Market Report 2024, The arthritis monoclonal antibodies market size has grown strongly in recent years. It will grow from $58.09 billion in 2023 to $62.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of arthritis, increasing awareness of arthritis monoclonal antibodies, expanding range of approved arthritis monoclonal antibodies, government support for research and development, increased investment from pharmaceutical companies.
The arthritis monoclonal antibodies market size is expected to see strongly grown in the next few years. It will grow to $83.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to combination therapies, expanding indications, patient preference, increased healthcare spending. Major trends in the forecast period include biosimilars and biobetters, targeted therapies, homecare administration, real-world evidence, cost and access considerations, advancements in drug delivery.
The increasing prevalence of arthritis globally has contributed to the growth of the arthritis monoclonal antibody market. According to the Global RA Network, in 2021, Over 350 million individuals worldwide suffer from arthritis and osteoarthritis is the most common form of arthritis followed by gout, fibromyalgia, and rheumatoid arthritis. According to WHO, the prevalence of rheumatoid arthritis varies between 0.3% and 1%, and the worldwide estimates of osteoarthritis include 9.6% of men and 18% of women. The increased prevalence of arthritis and the demand for personalized medicine are increasing the demand for the market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp
The arthritis monoclonal antibodies market covered in this report is segmented –
1) By Drug: Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima
2) By Application: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications
3) By End-Use: Hopitals, Research Institutes, Other End-Users
The combination of artificial intelligence and augmented reality shows many opportunities as both are separate but complementary technologies. Artificial intelligence models will enhance augmented reality experience by adding interactivity and effects to AR scenes like real-world object tagging, enabling an AR system to predict the appropriate interface for a person in each virtual environment, and enhances AR to create a multidimensional and responsive virtual experience that can bring in new levels of insight and creativity. For instance, in January 2022, AR’s Games, an Italian gaming firm announced that it is set to launch the world’s first artificial intelligence-based augmented reality video game. This game combines artificial intelligence and augmented reality to develop a first-person shooting game made with real people. It is named The Real Tournament and made exclusively for mobile devices. This combination will boost the augmented reality software market growth during the forecast period.
The arthritis monoclonal antibodies market report table of contents includes:
1. Executive Summary
- Arthritis Monoclonal Antibodies Market Characteristics
- Arthritis Monoclonal Antibodies Market Trends And Strategies
- Arthritis Monoclonal Antibodies Market – Macro Economic Scenario
- Global Arthritis Monoclonal Antibodies Market Size and Growth
. - Global Arthritis Monoclonal Antibodies Market Competitive Benchmarking
- Global Arthritis Monoclonal Antibodies Market Competitive Dashboard
- Key Mergers And Acquisitions In The Arthritis Monoclonal Antibodies Market
- Arthritis Monoclonal Antibodies Market Future Outlook and Potential Analysis
- Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
